All News

November 26, 2024

Novel genetics approach enhances discovery of disease risk genes

VUMC researchers applied the new approach to large GWAS datasets for breast, prostate and lung cancers, and three brain disorders.

November 26, 2024

VUMC again named a Comprehensive Radiopharmaceutical Therapy Center of Excellence

Radiopharmaceutical therapy is targeted delivery of radiation to cancer cells or to the tumor microenvironment using radiopharmaceuticals.

After being diagnosed with severe preeclampsia thanks to a blood pressure check at the 2024 Celebration of Motherhood, Jamye and Austin Willé spent a month in VUH and 89 days in the NICU at Monroe Carell Jr. Children's Hospital at Vanderbilt with their daughter, Akemi.
November 26, 2024

Patient’s family experiences healing power of music

Music therapy focuses on the use of music to help patients with chronic pain, physical rehabilitation, psychiatric symptoms, end of life, procedural support and coping with hospitalization and disease.

November 26, 2024

VUMC makes first appearance in national supply chain ranking

Vanderbilt Health placed 25th in the Gartner Healthcare Supply Chain Top 25 for 2024, released by Gartner Inc., a technology research and consulting firm.

During the 23rd annual Levi Watkins Jr., MD Lecture, individuals were honored for noteworthy contributions that reflect Watkins’ mission of improving health care for all people. From left are Consuelo Wilkins, MD, MSCI, Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence, Ariana Matos, Andrew Kittleson, speaker Constance Mobley, MD, PhD, Ebele Umeukeje, MD, MPH, Tia’Asia James, MD, and Kimberly Vinson, MD, associate dean for Diversity Affairs at Vanderbilt University School of Medicine. Wilkins and Vinson presented the awards. (photo by Erin O. Smith)
November 25, 2024

Lecture, awards honor legacy of Levi Watkins Jr., MD

Constance Mobley, PhD’98, MD’03, shared her journey to becoming a transplant surgeon, the research and clinical innovations she has contributed to during her career, and the wisdom she has gained through the years.

(iStock image)
November 25, 2024

Potential treatment eyed for abnormal blood cell disorder

Research could lead to improved diagnosis and the first effective treatment for the disorder, called “clonal hematopoiesis of indeterminate potential,” or CHIP.